Evidence map›Paper›PMID 42021413›Full record

ArticleActa neuropathologica communications2026

The octapeptide repeats of prion protein play critical roles in the pathogenesis of prion diseases.

Xiangyi Zhang, Jingjing Zhang, Yan Zhang, Dan Wang, Gaixiu Liu, Mengfei Wang, Chaoyang Li, Qi Shi, Xiaoping Dong, Chonggang Yuan and 2 more

Abstract read
In one paragraph

Article in Acta neuropathologica communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiangyi ZhangBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 102206, China.
Jingjing ZhangBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 102206, China.
Yan ZhangBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 102206, China.
Dan WangBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 102206, China.
Gaixiu LiuBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 102206, China.
Mengfei WangBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 102206, China.
Chaoyang LiCancer Research Institute, School of Basic Medical Sciences, University of South China, Hengyang, 421001, China.
Qi ShiNational key-Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Xiaoping DongNational key-Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Chonggang YuanKey Laboratory of Brain Functional Genomics (Ministry of Education and Shanghai), Institute of Brain Functional Genomics, School of Life Sciences and the Collaborative Innovation Center for Brain Science, East China Normal University, Shanghai, 200062, China.
Wenlong LiBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 102206, China.
Jiyan MaBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 102206, China. majiyan@cibr.ac.cn.

Funding

National Natural Science Foundation of China 31472213National Natural Science Foundation of China 31571059
6 · The paper itself

Abstract

Prion protein (PrP) is essential for the pathogenicity of prion diseases, a group of fatal neurodegenerative disorders affecting both humans and animals. The octapeptide repeats (OR) of PrP is a highly conserved structural feature; however, conflicting observations—that OR expansion causes inherited prion diseases while being dispensable for prion transmission—obscure its role in these disorders. We developed ΔOR mice by deleting the OR from the endogenous PrP-encoding gene, PRNP, which resulted in significantly prolonged survival times for mice inoculated with any of the five prion strains. Although disease characteristics were similar between terminally ill ΔOR and wild-type mice, the aggregation and conversion of PrP to the misfolded PrPSc were substantially delayed in ΔOR mice. This delay is attributable to reduced OR-OR self-association and diminished interactions between OR and the positively charged N-terminus of PrP. Additionally, the neurotoxic phase of the disease was both delayed and significantly prolonged in ΔOR mice. Our findings demonstrate the critical roles of OR in both PrP misfolding and neurotoxicity in prion diseases, highlighting OR as a promising therapeutic target that can mitigate both essential pathogenic processes in prion diseases.

Indexed as

Prion DiseasesPrion ProteinsPrionsAnimalsBrainDisease Models, AnimalMiceMice, TransgenicPrion ProteinsPrionsNeurodegenerationOctapeptide repeatsPrion diseasePrion proteinPrion transmission

Identifiers

PMID42021413
PMCPMC13251052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.